Skip to Content
Merck
CN

69771

L-(+)-Lactic acid

≥99.0% (T)

Synonym(s):

(S)-2-Hydroxypropionic acid, Sarcolactic acid

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C3H6O3
CAS Number:
Molecular Weight:
90.08
EC Number:
201-196-2
UNSPSC Code:
12161700
PubChem Substance ID:
Beilstein/REAXYS Number:
1720251
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


assay

≥99.0% (T)

impurities

≤1.0% water

solubility

H2O: 10 mg/mL, clear, colorless

suitability

suitable as substrate for LDH test

storage temp.

2-8°C

SMILES string

C[C@H](O)C(O)=O

InChI

1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m0/s1

InChI key

JVTAAEKCZFNVCJ-REOHCLBHSA-N

Preparation Note

from D-glucose fermentation by Rhizopus oryzae.

Other Notes

In studies on rat kidney l-2-hydroxyacid oxidase


Still not finding the right product?

Explore all of our products under L-(+)-Lactic acid


pictograms

Corrosion

signalword

Danger

hcodes

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1C

supp_hazards

Storage Class

8A - Combustible corrosive hazardous materials

wgk

WGK 1

flash_point_f

230.0 °F - closed cup

flash_point_c

110.00 °C - closed cup

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



P Urban et al.
Biochemistry, 27(19), 7365-7371 (1988-09-20)
Hydroxyacid oxidase from rat kidney is an FMN-dependent enzyme that catalyzes the oxidation of L-alpha-hydroxy acids as well as, more slowly, that of L-alpha-amino acids. We report here a modified purification method for the enzyme, which is found to possess
T Isotalo et al.
BJU international, 88(1), 30-34 (2001-07-12)
To assess whether patients in acute urinary retention from benign prostatic enlargement can be treated with a combined therapy comprising finasteride and a bioabsorbable self-reinforced poly L-lactic acid (SR-PLLA) urethral stent. Fifty-five patients in acute urinary retention were treated as
M Fulop et al.
The American journal of medicine, 80(2), 191-194 (1986-02-01)
In order to assess the frequency and severity of lactic acidosis and 3-hydroxybutyric acidosis in ethanol abusers, 29 patients who presented to an emergency room with acute intoxication were tested. Most were also chronic ethanol abusers but were not otherwise